Inpharma Weekly

, Volume 1196, Issue 1, pp 7–7 | Cite as

Dolasetron preferred for PONV prophylaxis

Newsletter Article


Marginal Cost Direct Medical Cost Droperidol Significant Adverse Event Rescue Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 1999

Personalised recommendations